HealthCare Management

Jim Tananbaum Acknowledges the Role Played by Mindstrong Health in Diagnosing and Treating Patients Suffering from Cognitive Health Disorders

Recently, Mindstrong Health revealed that it had secured $14 million in a Series-A round of funding. Mindstrong Health is a startup geared towards utilizing smartphones to diagnose and help treat neuropsychiatric disorders. The round of financing drew numerous investors including One Mind Brain Health Impact Fund, Foresite Capital, Berggruen Holdings and Optum Ventures. Both ARCH Venture Partners and Jim Tananbaum’s Foresite Capital Management led the funding.

Mindstrong boasts of a platform that utilizes a patient’s patterns of typing and scrolling on a smartphone to measure his or her brain function. In turn, the platform offers information regarding the cognition and mood biomarkers, which include function, memory and processing speed.

Jim Tananbaum cited in the release that Mindstrong Health’s founding team provides a unique understanding of the fundamental problems surrounding the manner by which the medical community deals with patients of cognitive health disorders. Paul Dagum, the founder and CEO of Mindstrong, also emphasized the need for objective measures that are synonymous to those used for other chronic diseases like heart disease in a bid to boost outcomes for individuals suffering from mental disorders. Visit Ideamensch to know more.

Jim Tananbaum

According to INC42, Jim Tananbaum serves as the founder and CEO of Foresite Capital, which has about $1.1 billion in AUM. Foresite Capital Management integrates the excellent practices of growth investing with specialization in healthcare. Jim has continuously steered the company into investing in companies with late-stage, disruptive services and products in various sectors of healthcare like diagnostics, medical devices, genomics, biotechnology and healthcare services. Away from Foresite Capital, he is acknowledged for leading investments in 21 healthcare companies including Jazz Pharmaceuticals and Amerigroup.

Jim is well-known for many accomplishments in the pharmaceutical industry including introducing two drugs into the market for less than $80 million under his company, GelTex Pharmaceuticals. Currently, the drugs rake in $1 billion in revenue. GelTex was bought for a whopping $1.6 billion. Jim is also the brains behind the inception of Theravance Inc. Aside from business, he is a well-educated business executive. Jim Tananbaum has an MD from Harvard Medical School, an MS from MIT, an MBA from Harvard Business School, as well as a BSEE and BS from Yale University.

See more: https://www.researchgate.net/profile/Jim_Tananbaum

Rick Shinto and InnovaCare: Providing Accessible Health Care Solutions

InnovaCare is a health care management organization, which provides packaged Medicare plans and related physician services. According to its CEO, Rick Shinto InnovaCare Health works in seamless harmony standing behind solid core principles, team driven initiatives and the establishment of effective communication. As an organization InnovaCare Health Solutions, LLC is a leader in the field of managed health care. The company has its main headquarters in New Jersey, with additional affiliate locations in Puerto Rico.

When asked about his leadership role, Rick Shinto is quick to deflect the spotlight from himself as a solo entity, back onto what InnovaCare offers as a physician services provider. Because there’s also equal praise for the level of customer satisfaction, which has a very high rating of 90% and InnovaCare’s quality assurance ratings are also exemplary. Exceptional services means to consistently “exceed the customer’s expectations,” Rick Shinto’s leadership is reflected in the NCQA accreditation. NCQA is the highest level of accreditation, it’s a report card for measuring the level of improvement in the area of quality assurance.

Learn more: http://xrepublic.net/2016/12/09/rick-shinto-a-career-behind-healthcare/

Rick Shinto has been in the healthcare management field for over twenty years. He began his career as an Interventional Pulmonologist and served as Chief Medical Officer for Cal Optima Health Plan before joining InnovaCare. He’s credited with playing a key role in leading InnovaCare to success, along with Penelope Kokkinides and Jonathan Meyers.

When he was named InnovaCare CEO in 2012, it didn’t take Rick Shinto long before he built an organization of substance. InnovaCare has established a reputation for taking the red tape out of Medicare Advantage plans and making it affordable for the average person to receive quality healthcare. This also applies to the standards in Puerto Rico. As a managed solution, InnovaCare has been selected the most of all enrolled healthcare plans. Puerto Ricans have experienced upgraded medical services as a result of InnovaCare providing plans that they can afford.

Prior to his tenure at InnovaCare, as a young CEO, Rick Shinto worked for Aveta Inc., where he was selected for professional merit; receiving the Ernst & Young Entrepreneur Of The Year Award. The award is given to individuals who display outstanding service and excellence in financial performance. Of this merit, Rick Shinto said, “I’m honored to be the recipient of such a prestigious award.” For him, it was only the beginning of a team focused professional ideology. Read more at intelius.com about Rick Shinto.

InnovaCare Boasts Great Leadership During Unsettled Times

Leadership means everything in any organization. Often an organization exists because of the leader who founded it. InnovaCare Health has two fabulous leaders in their respective areas for moving forward since the advent of socialized medicine in the United States, a country that once had the most vibrant, brilliant and quality healthcare system in the world. It is now in danger of falling into the abyss of government run healthcare, separating patients from their doctors in important decision making on hrmronline.com. The long lines for vital care will lengthen and many people in dire need could perish in the waiting periods they once never had during the era of freely offered healthcare choices.

It is a tragedy that for a handful of low income people with the false narrative of being turned away by their insurance companies for treatment of preexisting conditions that the overwhelming majority of Americans now have been saddled with a system that raised their rates to phenomenal levels as wells their deductibles so that care is now offered that a man does not need, such as a one size fits all policy that includes prenatal care.

Fortunately, Rick shinto, M.D., MBA and President and Chief Executive Officer of InnovaCare, and Penelope Kokkinides, Chief Administrative Officer with more than two decades of bureaucratic healthcare experience are teaming up to make sense of what has become of the healthcare system of the United States. They are using models that have been put in place in Puerto Rico. These plans that are available to the people in Puerto Rico are showing high levels of efficiency, cost effectiveness and satisfaction.

Read more: Aveta Inc. President & CEO Rick Shinto, M.D. Receives Ernst & Young Entrepreneur Of The Year® Award

Both patients and providers are finding that they are able to reach their goals of proper treatment and healthcare despite governmental interventions.

InnovaCare is now the leading provider of Medicaid and Medicare Advantage plans in the network of medical services provided by physicians. The number one concern of the participants in these provider plans is to give quality healthcare to the patients who subscribe to these plans. The characteristics reflect a sound plan with cost-saving models that are totally tied into frontier medical research and technologies on bizjournals.com. This socialized medical system will not shackle the patients and providers into falling behind into a less than innovative healthcare system just because of bureaucratic strings and ropes that could bind it.

Everyone who works behind the scenes at InnovaCare are bound to the mission of doing all that they can to support the patients as their number one priority in an unsettling and nebulous environment for the future of healthcare.